Total Payments
$58,272
2024 Payments
$4,686
Companies
60
Transactions
484
Medicare Patients
2,035
Medicare Billing
$278,998
Payment Breakdown by Category
Other$30,765 (52.8%)
Food & Beverage$15,519 (26.6%)
Consulting$9,565 (16.4%)
Education$2,239 (3.8%)
Travel$184.03 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,765 | 24 | 52.8% |
| Food and Beverage | $15,519 | 419 | 26.6% |
| Consulting Fee | $9,565 | 5 | 16.4% |
| Education | $2,239 | 34 | 3.8% |
| Travel and Lodging | $184.03 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $20,363 | 46 | $0 (2020) |
| Celgene Corporation | $11,562 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,689 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $3,491 | 41 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $1,966 | 8 | $0 (2024) |
| Exelixis Inc. | $1,681 | 6 | $0 (2023) |
| Eisai Inc. | $1,570 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $1,049 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $949.25 | 29 | $0 (2024) |
| Incyte Corporation | $918.66 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,686 | 87 | Janssen Biotech, Inc. ($2,258) |
| 2023 | $4,872 | 100 | Puma Biotechnology, Inc. ($1,879) |
| 2022 | $3,931 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,182) |
| 2021 | $800.92 | 12 | AbbVie Inc. ($136.76) |
| 2020 | $2,763 | 10 | Eisai Inc. ($1,380) |
| 2019 | $9,381 | 70 | Genentech USA, Inc. ($4,856) |
| 2018 | $17,230 | 90 | Genentech USA, Inc. ($6,904) |
| 2017 | $14,608 | 67 | Genentech USA, Inc. ($8,544) |
All Payment Transactions
484 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.81 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: Hematology | ||||||
| 12/05/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Oncology | ||||||
| 11/20/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $33.17 | General |
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Oncology | ||||||
| 10/31/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/10/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $21.88 | General |
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 456 | 1,971 | $162,621 | $61,311 |
| 2022 | 10 | 417 | 1,580 | $134,201 | $59,092 |
| 2021 | 16 | 537 | 2,011 | $178,625 | $75,662 |
| 2020 | 15 | 625 | 2,275 | $249,186 | $82,933 |
Total Patients
2,035
Total Services
7,837
Medicare Billing
$278,998
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 236 | $35,400 | $17,189 | 48.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 90 | $31,500 | $11,077 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 181 | $18,100 | $9,008 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 73 | $18,250 | $7,384 | 40.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 16 | 224 | $16,800 | $6,084 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,200 | $3,141 | 34.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 100 | 328 | $6,540 | $2,488 | 38.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 293 | $2,930 | $2,461 | 84.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 114 | $5,700 | $1,401 | 24.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 42 | $16,600 | $989.06 | 6.0% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2023 | 11 | 211 | $850.41 | $50.20 | 5.9% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 12 | 75 | $750.00 | $38.37 | 5.1% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 15 | 81 | $0.81 | $0.81 | 100.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 259 | $38,850 | $20,850 | 53.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 100 | $35,000 | $13,660 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 152 | $15,200 | $8,167 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 70 | $17,500 | $7,321 | 41.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $12,400 | $4,254 | 34.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 99 | 369 | $7,380 | $2,828 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 72 | $3,600 | $987.42 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 100 | 329 | $3,290 | $973.77 | 29.6% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 11 | 98 | $980.00 | $51.23 | 5.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 12 | 100 | $1.00 | $1.00 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 402 | $58,490 | $33,989 | 58.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 96 | $40,200 | $14,382 | 35.8% |
About Zili He
Zili He is a Hematology & Oncology healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598709388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Zili He has received a total of $58,272 in payments from pharmaceutical and medical device companies, with $4,686 received in 2024. These payments were reported across 484 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,765).
As a Medicare-enrolled provider, He has provided services to 2,035 Medicare beneficiaries, totaling 7,837 services with total Medicare billing of $278,998. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Flushing, NY
- Active Since 06/15/2006
- Last Updated 04/12/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598709388
Products in Payments
- Abraxane (Drug) $11,222
- TECENTRIQ (Biological) $8,972
- Avastin (Biological) $6,368
- Alecensa (Biological) $4,831
- GILOTRIF (Drug) $2,404
- TALVEY (Biological) $1,950
- Lenvima (Drug) $1,570
- Cabometyx (Drug) $1,550
- IMBRUVICA (Drug) $914.95
- Vemlidy (Drug) $840.85
- KEYTRUDA (Biological) $720.02
- CREON (Drug) $691.45
- OPDIVO (Biological) $554.31
- JAKAFI (Drug) $285.95
- TAGRISSO (Drug) $247.54
- DARZALEX (Biological) $242.52
- BRUKINSA (Drug) $226.94
- ERLEADA (Drug) $226.10
- FOUNDATIONONE (Device) $225.00
- VERZENIO (Drug) $204.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Flushing
Dr. Yun Hee Chung, Md, MD
Hematology & Oncology — Payments: $72,616
Hematology & Oncology $72,616
Dr. Ber-Yuh Yang, M.d, M.D
Hematology & Oncology — Payments: $24,456
Hematology & Oncology $24,456
Dr. Hua Huang, Md, MD
Hematology & Oncology — Payments: $6,309
Hematology & Oncology $6,309
Dr. Barbara Seligman, M.d, M.D
Hematology & Oncology — Payments: $6,014
Hematology & Oncology $6,014
Dr. Jyming Wang, M.d, M.D
Hematology & Oncology — Payments: $2,940
Hematology & Oncology $2,940
Richard Xu, M.d, M.D
Hematology & Oncology — Payments: $2,097
Hematology & Oncology $2,097